[HTML][HTML] Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice

D Chinnasamy, Z Yu, MR Theoret… - The Journal of …, 2010 - Am Soc Clin Investig
Immunotherapies based on adoptive cell transfer are highly effective in the treatment of
metastatic melanoma, but the use of this approach in other cancer histologies has been …

[PDF][PDF] Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice

D Chinnasamy, Z Yu, MR Theoret, Y Zhao, RK Shrimali… - researchgate.net
Immunotherapies based on adoptive cell transfer are highly effective in the treatment of
metastatic melanoma, but the use of this approach in other cancer histologies has been …

Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice

D Chinnasamy, Z Yu, MR Theoret, Y Zhao… - Journal of Clinical …, 2010 - go.gale.com
Immunotherapies based on adoptive cell transfer are highly effective in the treatment of
metastatic melanoma, but the use of this approach in other cancer histologies has been …

Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice

D Chinnasamy, Z Yu, MR Theoret… - Journal of Clinical …, 2010 - search.proquest.com
Immunotherapies based on adoptive cell transfer are highly effective in the treatment of
metastatic melanoma, but the use of this approach in other cancer histologies has been …

[HTML][HTML] Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice

D Chinnasamy, Z Yu, MR Theoret, Y Zhao… - The Journal of …, 2010 - ncbi.nlm.nih.gov
Immunotherapies based on adoptive cell transfer are highly effective in the treatment of
metastatic melanoma, but the use of this approach in other cancer histologies has been …

Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice

D Chinnasamy, Z Yu, MR Theoret… - Journal of Clinical …, 2010 - pure.johnshopkins.edu
Immunotherapies based on adoptive cell transfer are highly effective in the treatment of
metastatic melanoma, but the use of this approach in other cancer histologies has been …

[引用][C] Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice

D Chinnasamy, Z Yu, MR Theoret, Y Zhao… - Journal of Clinical …, 2010 - cir.nii.ac.jp
Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth
of vascularized syngenic tumors in mice | CiNii Research CiNii 国立情報学研究所 学術情報 …

Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice.

D Chinnasamy, Z Yu, MR Theoret, Y Zhao… - The Journal of …, 2010 - europepmc.org
Immunotherapies based on adoptive cell transfer are highly effective in the treatment of
metastatic melanoma, but the use of this approach in other cancer histologies has been …

[PDF][PDF] Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice

D Chinnasamy, Z Yu, MR Theoret, Y Zhao, RK Shrimali… - Am Soc Clin Investig
Immunotherapies based on adoptive cell transfer are highly effective in the treatment of
metastatic melanoma, but the use of this approach in other cancer histologies has been …

Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice

D Chinnasamy, Z Yu, MR Theoret… - The Journal of …, 2010 - pubmed.ncbi.nlm.nih.gov
Immunotherapies based on adoptive cell transfer are highly effective in the treatment of
metastatic melanoma, but the use of this approach in other cancer histologies has been …